Star Equity Research Development Over Time
| STRR Stock | USD 10.15 0.16 1.60% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Star Equity Performance and Star Equity Correlation. Can Biotechnology industry sustain growth momentum? Does Star have expansion opportunities? Factors like these will boost the valuation of Star Equity. If investors know Star will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Star Equity demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.22) | Earnings Share (1.59) | Revenue Per Share | Quarterly Revenue Growth 0.301 | Return On Assets |
Understanding Star Equity Holdings requires distinguishing between market price and book value, where the latter reflects Star's accounting equity. The concept of intrinsic value - what Star Equity's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Star Equity's price substantially above or below its fundamental value.
Please note, there is a significant difference between Star Equity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Star Equity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Star Equity's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Research Development Analysis
Compare Star Equity Holdings and related stocks such as Inotiv Inc, bioAffinity Technologies, and Neuroone Medical Tec Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NOTV | 1.6 M | 542 K | 454 K | 658 K | 715 K | 496 K | 465 K | 596 K | 627 K | 950 K | 405 K | 405 K | 405 K | 405 K | 405 K | 364.5 K | 346.3 K |
| BIAF | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.6 M | 1.3 M | 1.5 M | 1.7 M | 1.8 M | 2.1 M | 1.8 M |
| NMTC | 2.4 K | 2.4 K | 2.4 K | 2.4 K | 2.4 K | 735.3 K | 735.3 K | 951.1 K | 1.5 M | 2.1 M | 3.9 M | 4.9 M | 6.9 M | 5.1 M | 5 M | 5.7 M | 3.2 M |
| YI | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 48.1 M | 71.2 M | 61.9 M | 92.1 M | 189.3 M | 139.5 M | 124.3 M | 124.3 M | 143 M | 108.4 M |
| ECOR | 8 M | 8 M | 8 M | 8 M | 8 M | 8 M | 8 M | 7.8 M | 12.5 M | 9.9 M | 4.2 M | 2.5 M | 5.5 M | 5.3 M | 2.4 M | 2.1 M | 2 M |
| DYAI | 3.6 M | 950 K | 921.7 K | 1 M | 2.2 M | 124 K | 885.6 K | 2.2 M | 3.3 M | 5.4 M | 3.9 M | 8.4 M | 4.5 M | 3.3 M | 2 M | 2.4 M | 3 M |
| LIMN | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 1.9 M | 3.8 M | 2.7 M | 2.4 M | 2.4 M |
| BDSX | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 10.5 M | 10.8 M | 12.8 M | 13.1 M | 10 M | 9.6 M | 11 M | 11.8 M |
| PRPO | 6.3 M | 2.2 M | 2.5 M | 3.2 M | 2.9 M | 1.9 M | 1.4 M | 500 K | 1.1 M | 2.8 M | 2.2 M | 1.3 M | 1.7 M | 2.7 M | 2.3 M | 2.1 M | 2.9 M |
| ELUT | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.4 M | 6 M | 9.3 M | 7.7 M | 4.4 M | 3.8 M | 4.4 M | 5.7 M |
Star Equity Holdings and related stocks such as Inotiv Inc, bioAffinity Technologies, and Neuroone Medical Tec Research Development description
My Equities
My Current Equities and Potential Positions
| Star Equity Holdings | STRR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 53 Forest Avenue, |
| Exchange | NASDAQ Exchange |
USD 10.15
Additional Tools for Star Stock Analysis
When running Star Equity's price analysis, check to measure Star Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Equity is operating at the current time. Most of Star Equity's value examination focuses on studying past and present price action to predict the probability of Star Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Equity's price. Additionally, you may evaluate how the addition of Star Equity to your portfolios can decrease your overall portfolio volatility.